Fresenius Kabi Austria GmbH specializes in products for infusion and nutrition therapy.
We develop, produce and distribute a full portfolio of IV generic drugs and nutrition products. With these product groups we are one of the leading companies in the Austrian hospital and homecare sectors.
Our ultimate goal is to meet the needs and expectations of our customers. The quality of our products and services is synonymous with improving the quality of life of our patients.
Our plants in Graz and Linz manufacture products for both the Austrian market and for export markets around the world, with an export rate of approximately 80%. Besides sterile pharmaceuticals, we are also one of the world's largest manufacturers of the carbohydrate pharmaceutical ingredients hydroxyethyl starch (HES) and lactulose.
As a reliable contracting partner, we offer our comprehensive development and manufacturing competences to third parties.
Fresenius Kabi Austria, with approximately 1,550 employees, is a subsidiary of Fresenius Kabi AG.
Fresenius Kabi AG, in turn, is a division of the international healthcare company Fresenius SE & Co KGaA.
Fresenius Kabi employs more than 40,500 people worldwide.
With our corporate philosophy of "caring for life", we are committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face.